Vera Therapeutics VERA
NASDAQ VERA
$31.02 +0.96 (+3.19%)
As of: Oct 21, 2026 · 2:45 PM EDT

Vera Therapeutics (VERA) Restructuring Costs (2020 - 2021)

Updated

Vera Therapeutics' Restructuring Costs came in at -$116,000 for Q4 2021, compared with $1.58 million a year earlier.

Analysis

Vera Therapeutics (VERA) Restructuring Costs (2020 - 2021) Analysis & Trends

For FY2020, Vera Therapeutics' Restructuring Costs was $3 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn
10 Vera Therapeutics 2.23 Bn -77.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -116,000.00
Dec 31, 2020 1.58 Mn
Sep 30, 2020 1.42 Mn
API Access

Vera Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=VERA&period=max&api_key=YOUR_API_KEY